National and Kapodistrian University of Athens
Διερεύνηση της εξέλιξης των μεταβολικών διαταραχών στη σήψη και τη σηπτική καταπληξία
Abstract
dc:descriptionWe have shown for the first time that adiponectin increases and resistin decreases during the course of prolonged sepsis. These changes were most evident in patients who recovered from the critical state and were associated with the reduction of the inflammatory response, as this was assessed by the levels of proinflammatory cytokines. Adiponectin levels correlated with growth hormone levels, suggesting a positive effect of growth hormone in adiponectin secretion. Resistin levels mainly related to the severity of sepsis and the degree of the inflammatory response suggesting that the main role of resistin in humans is that of an acute phase protein. We also characterized the changes of crucial stress hormones during prolonged sepsis. Patients with the worst prognosis had significantly higher cortisol levels, both basal and post ACTH stimulation, higher growth hormone levels and lower DHEA-S levels. We also observed a gradual increase of ACTH and DHEA concentrations in the course of sepsis; this finding has not been described previously. In conclusion, diverse endocrine and metabolic adaptations occur in critical illness. Characterizing these changes opens the way for planning better treatments for these patients, aiming at improving survival and accelerate recovery. Towards this direction further studies are needed to delineate the underlying pathophysiological mechanisms and to clarify which of these changes are beneficial and which maladaptive in order to design clinical trials aiming to modify those changes that are harmful. For example an early increase of adiponectin and a reduction of resistin theoretically could have a beneficial effect in reducing the inflammatory response and the marked insulin resistance. However, the production of biosynthetic adiponectin for exogenous administration has significant limitations as the molecule is subject to several post-translational modifications. Furthermore it circulates at very high plasma concentrations (5-30 mg /ml) and has a relatively short half-life so that high amounts of recombinant protein and frequent administration would be required. An alternative approach would be to increase endogenous adiponectin. The administration PPAR-γ agonists has the advantage of increasing the adiponectin and simultaneously reduce the levels of resistin. Existing PPAR-γ agonists, thiazolidinediones, have several side effects such as fluid retention resulting in peripheral edema and heart failure, and therefore they are not suitable for use in ICU patients. Possibly newer more selective PPAR-γ agonists may prove useful in the future.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vassiliadi, Dimitra-Argyro
- Βασιλειάδη, Δήμητρα-Αργυρώ
Subjects
dc:subject × 20Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29757